Anti-inflammatory effect of rosiglitazone is not reflected in expression of NFκB-related genes in peripheral blood mononuclear cells of patients with type 2 diabetes mellitus

BACKGROUND: Rosiglitazone not only improves insulin-sensitivity, but also exerts anti-inflammatory effects. We have now examined in type 2 diabetic patients if these effects are reflected by changes in mRNA expression in peripheral blood mononuclear cells (PBMCs) to see if these cells can be used to...

Descripción completa

Detalles Bibliográficos
Autores principales: Bragt, Marjolijn CE, Plat, Jogchum, Mensink, Marco, Schrauwen, Patrick, Mensink, Ronald P
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2653037/
https://www.ncbi.nlm.nih.gov/pubmed/19243600
http://dx.doi.org/10.1186/1472-6823-9-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2653037/
https://www.ncbi.nlm.nih.gov/pubmed/19243600
http://dx.doi.org/10.1186/1472-6823-9-8

Ejemplares similares